Showing results (401-410 of 479) with videos related to
Sort By:
Pageof 48
Cancer|October 27, 2020
Case study of the integration of electronic patient-reported outcomes as standard of care in a head and neck oncology practice: Obstacles and opportunitiesOlga Strachna, Marc A Cohen, Monica M Allison, et al.Revue D'Epidemiologie Et De Sante Publique|October 1, 1996
[Living conditions of prostitutes: consequences for the prevention of HIV infection]A Serre, M Schutz-Samson, C Cabral, et al.ACR Open Rheumatology|October 4, 2024
Therapeutic JAK1 Inhibition Reverses Lupus Nephritis in a Mouse Model and Demonstrates Transcriptional Changes Consistent With Human DiseaseRachel E Twomey, Stuart J Perper, Susan V Westmoreland, et al.Nucleic Acids Research|September 21, 2007
Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzymeFeng Li, Pradeep S Pallan, Martin A Maier, et al.Cancer|January 23, 2014
Impact of obesity on the survival of patients with early-stage squamous cell carcinoma of the oral tongueNeil M Iyengar, Amit Kochhar, Patrick G Morris, et al.International Journal of Radiation Oncology, Biology, Physics|November 4, 2019
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell CarcinomaLara A Dunn, Nadeem Riaz, Matthew G Fury, et al.Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancerK M Pisters, L B Tyson, W Tong, et al.JAMA Oncology|January 20, 2022
Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive ChemoradiotherapyC Jillian Tsai, Sean M McBride, Nadeem Riaz, et al.The Journal of Pathology|May 12, 2017
Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomasSnjezana Dogan, Deborah J Chute, Bin Xu, et al.Pageof 48